Cristina Blaj
Revolution Medicines (United States)(US)
Publications by Year
Research Areas
Cancer Research and Treatments, Cancer, Hypoxia, and Metabolism, ATP Synthase and ATPases Research, Mechanisms of cancer metastasis, Cancer Cells and Metastasis
Most-Cited Works
- → Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy(2024)279 cited
- → Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers(2024)240 cited
- → PBX3 Is Part of an EMT Regulatory Network and Indicates Poor Outcome in Colorectal Cancer(2018)110 cited
- → Joint single cell DNA-seq and RNA-seq of gastric cancer cell lines reveals rules of in vitro evolution(2020)104 cited
- → Oncogenic Effects of High MAPK Activity in Colorectal Cancer Mark Progenitor Cells and Persist Irrespective of RAS Mutations(2017)85 cited
- → Multicolor lineage tracing reveals clonal architecture and dynamics in colon cancer(2017)54 cited
- → Synergy of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I–deficient and MHC I + tumors(2022)42 cited
- → ADNP Is a Therapeutically Inducible Repressor of WNT Signaling in Colorectal Cancer(2016)36 cited
- → Targeting tumor cell plasticity by combined inhibition of NOTCH and MAPK signaling in colon cancer(2018)34 cited
- → Abstract 1260: First-in-class, orally bioavailable KRASG12V(ON) tri-complex inhibitors, as single agents and in combinations, drive profound anti-tumor activity in preclinical models of KRASG12V mutant cancers(2021)33 cited